1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study

Sousa, Maria João; Caramujo, Cecília; Julio, N.; Magalhães, Joana; Basto, Raquel; Fraga, Teresa; Gomes, Inês; Pazos, Isabel; Sousa, Gabriela

doi:10.1016/j.annonc.2021.08.1591

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar results have been documented in a Portuguese study by de Sousa et al where a majority of cancer patients (84%) on immunosuppressive therapy had the intention to be vaccinated, as well as a Lebanese study where 55% of patients had shown willingness for COVID-19 vaccination [ 46 ].…”

Section: Discussionsupporting

confidence: 86%

Acceptance, effects, and tolerability in the vaccination process against SARS-CoV-2 virus among cancer patients in Bosnia and Herzegovina: a single-center cross-sectional study

Cerić

Sokolović

Pašić

et al. 2022

Bosn J of Basic Med Sci

View full text Add to dashboard Cite

The pandemic of SARS-CoV-2 has been the main health public issue since the end of 2019. Vaccination campaign in B&H started in April 2021 with several vaccines available. Our study aimed to evaluate acceptance, effects and tolerability of vaccines against SARS-COV 2 virus among cancer patients. We have conducted cross-sectional, observational study between 22nd October and 30th November 2021 at the Clinic of Oncology, Clinical Center University of Sarajevo. Patients were randomly enrolled during their regular visit to the Clinic of Oncology by agreeing to fill in an individual paper questionnaire. The study included 1063 patients with malignant disease of which 681 (64.1%] were fully vaccinated patients. In study population 76.9% of patients reported that they did not have any side effects of vaccination, while only 0.5% of patients had delay in their treatment caused by side effects of vaccination. Among fully vaccinated patients there were 40 patients (3.8%] who were infected with SARS-CoV-2 after the second or booster dose of vaccine. Five patients (0.5%] were hospitalized because of COVID-19 after being fully vaccinated. Findings of our study suggest that cancer patients have higher acceptance of vaccines against SARS-CoV-2 than general population in Bosnia and Herzegovina. Side effects of vaccines are tolerable and do not cause major delay of specific cancer treatment. Protective effects of SARS-CoV-2 vaccines in cancer patients presented in our study are comparable to available results of similar studies which included general population.

show abstract

Section: Discussionsupporting

confidence: 86%

Acceptance, effects, and tolerability in the vaccination process against SARS-CoV-2 virus among cancer patients in Bosnia and Herzegovina: a single-center cross-sectional study

Cerić

Sokolović

Pašić

et al. 2022

Bosn J of Basic Med Sci

View full text Add to dashboard Cite

show abstract

“…This vaccination rate is higher than the global and European Union rates (46.3% and 68.1%, respectively) [40]. In a study conducted among Portuguese immunosuppressed cancer patients three months after implementing the vaccination program, the vaccine acceptance was 84.0% [39]. However, in a prior cross-sectional analysis of the Portuguese communitybased survey "COVID-19 Barometer: Social Opinion" using data from 29 September 2020 to 8 January 2021, only 35.3% of the individuals would like to be vaccinated as soon as possible, with most (55.5%) preferring to wait some time before being vaccinated and 9.2% refusing the vaccination [38].…”

Section: Introductionmentioning

confidence: 96%

Factors Associated with COVID-19 Vaccine Hesitancy after Implementation of a Mass Vaccination Campaign

et al. 2022

View full text Add to dashboard Cite

An online cross-sectional study on COVID-19 vaccination adhesion was conducted in Portugal nine months after vaccination rollout (September–November 2021). Logistic regression was used to identify factors associated with hesitancy to take the COVID-19 vaccine in the community-based survey, “COVID-19 Barometer: Social Opinion”. Hesitancy was 11%; however, of those, 60.5% stated that they intended to take the vaccine. Hesitancy was associated with factors such as lower monthly household income; no intention of taking the flu vaccine this year; perceived reasonable health status; having two or more diseases; low confidence in the health service response; worse perception of the adequacy of anti-COVID-19 government measures; low or no perceived risk of getting COVID-19; feeling agitated, anxious or sad some days; and lack of trust in the safety and efficacy of the vaccines. Confidence in vaccines, namely against COVID-19, is paramount for public health and should be monitored during vaccination rollout. Clear communication of the risks and benefits of vaccination needs improvement to increase adherence and public confidence.

show abstract

1598P Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study

Abstract: Background: Cancer p represent a high-risk population for severe COVID-19. Cancerassociated immunosuppression may hinder in the development of anti-SARS-CoV-2 antibodies.

Cited by 2 publications

References 0 publications

Acceptance, effects, and tolerability in the vaccination process against SARS-CoV-2 virus among cancer patients in Bosnia and Herzegovina: a single-center cross-sectional study

Acceptance, effects, and tolerability in the vaccination process against SARS-CoV-2 virus among cancer patients in Bosnia and Herzegovina: a single-center cross-sectional study

Factors Associated with COVID-19 Vaccine Hesitancy after Implementation of a Mass Vaccination Campaign

Contact Info

Product

Resources

About